Indication
Vitamin D deficiency
Vitamin D deficiency is a metabolic nutritional disorder characterized by inadequate levels of circulating 25-hydroxyvitamin D, leading to impaired intestinal absorption of calcium and phosphorus. Read more about Vitamin D deficiency
260 drugs 88 manufacturers
Drugs that treat it
Common Vitamin D deficiency therapies.
THERA-D (cholecalciferol (vitamin D3))
THERA-D (cholecalciferol (vitamin D3))
CAL MAG ZINC-D3 (calcium carbonate/vitamin D3/magnesium oxide/zinc oxide)
DECARA (cholecalciferol (vitamin D3))
CHOLECALCIFEROL (VITAMIN D3)
CHOLECALCIFEROL (VITAMIN D3)
CALTRATE PLUS (calcium carbonate/cholecalciferol (vit D3)/minerals)
DELTA D3 (cholecalciferol (vitamin D3))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVitamin D deficiency is a metabolic nutritional disorder characterized by inadequate levels of circulating 25-hydroxyvitamin D, leading to impaired intestinal absorption of calcium and phosphorus.
This condition primarily affects the skeletal system across pediatric and adult populations, commonly driven by insufficient dietary intake, malabsorption, or limited ultraviolet B sun exposure.
Pathophysiologically, the resulting hypocalcemia stimulates secondary hyperparathyroidism, which mobilizes calcium from bone and leads to defective mineralization.
Clinically, it manifests as rickets and impaired skeletal development in children, or osteomalacia, accelerated bone turnover, osteoporosis, and an increased risk of fragility fractures in adults.
- nih.gov
Vitamin D deficiency is a metabolic nutritional disorder characterized by inadequate levels of circulating 25-hydroxyvitamin D, leading to impaired intestinal absorption of calcium and phosphorus This condition primarily affects the skeletal system across pediatric and adult populations, commonly driven by insufficient dietary intake, malabsorption, or limited ultraviolet B sun exposure Pathophysiologically, the resulting hypocalcemia stimulates secondary hyperparathyroidism, which mobilizes cal...
- nih.gov
Vitamin D deficiency is a metabolic nutritional disorder characterized by inadequate levels of circulating 25-hydroxyvitamin D, leading to impaired intestinal absorption of calcium and phosphorus
- nih.gov
This condition primarily affects the skeletal system across pediatric and adult populations, commonly driven by insufficient dietary intake, malabsorption, or limited ultraviolet B sun exposure Pathophysiologically, the resulting hypocalcemia stimulates secondary hyperparathyroidism, which mobilizes calcium from bone and leads to defective mineralization
- nih.gov
Pathophysiologically, the resulting hypocalcemia stimulates secondary hyperparathyroidism, which mobilizes calcium from bone and leads to defective mineralization
- nih.gov
Clinically, it manifests as rickets and impaired skeletal development in children, or osteomalacia, accelerated bone turnover, osteoporosis, and an increased risk of fragility fractures in adults
Personalize your experience
Follow Vitamin D deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.